Abstract
Our aim was to check the suitability of the human intestine for the delivery of the re-combinant proteins in humans. The prospective applications of said technology are huge, since travel in the outer Space to locate new planets for the relocation of the over crowded Earth will face the need for the crew vaccination from the pathological microorganisms, found in these outer Space locations. We invented the technology to treat Diabetes II and his chronic anemia in the adult volunteer as the draft of said new applications of said in vivo technology. The strain of lactobacilli from normal human intestinal microflora was isolated, genetically engineered and then returned back for the adhesion back to the host intestinal epithelium of the volunteer. The volunteer was cured from his Diabetes II and chronic anemia. We discuss the potential applications of said technology for the in vivo expression of the vaccines for the crews of the outer space long range travel missions coming soon.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
